{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:59:57Z","timestamp":1792670397032,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jid.2025.12.036","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:47:28Z","timestamp":1769586448000},"page":"2159-2167.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo"],"prefix":"10.1016","volume":"146","author":[{"given":"Anand K.","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Rashighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Seneschal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethanee J.","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Crouthamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi S.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.12.036_bib1","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S2468-2667(24)00026-4","article-title":"Estimating the burden of vitiligo: a systematic review and modelling study","volume":"9","author":"Akl","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jid.2025.12.036_bib2","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/jdv.18257","article-title":"Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA","volume":"36","author":"Bibeau","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.12.036_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/bjd\/ljac074","article-title":"Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical trials","volume":"188","author":"Eleftheriadou","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bjd\/ljad366","article-title":"Assessment of treatment response on facial vitiligo, a step forward. But what about the neck?","volume":"190","author":"Eleftheriadou","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaad.2021.06.871","article-title":"Quantification of adverse skin reactions secondary to mask wearing using 3-dimensional imaging technology: a prospective cohort study","volume":"87","author":"Elsanadi","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2022.11.005","article-title":"Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase 2b clinical trial","volume":"88","author":"Ezzedine","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamadermatol.2024.4534","article-title":"Psychometric properties and meaningful change thresholds of the Vitiligo Area Scoring Index","volume":"161","author":"Ezzedine","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jamadermatol.2021.4724","article-title":"Prevalence of vitiligo among adults in the United States","volume":"158","author":"Gandhi","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000517900","article-title":"The additive value of 3D total body imaging for sequential monitoring of skin lesions: a case series","volume":"238","author":"Grochulska","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2025.12.036_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/lsm.23373","article-title":"Dermatologic scar assessment with stereoscopic imaging and digital three-dimensional models: a validation study","volume":"53","author":"Hendel","year":"2021","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jid.2025.12.036_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jid.2023.07.014","article-title":"Evaluation of facial vitiligo severity with a mixed clinical and artificial intelligence approach","volume":"144","author":"Hillmer","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/exd.12791","article-title":"Three-dimensional imaging of vitiligo","volume":"24","author":"Kohli","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjd.13432","article-title":"Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo","volume":"172","author":"Komen","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdcr.2024.01.033","article-title":"Upadacitinib and its role in the treatment of vitiligo: a new possible therapeutic perspective","volume":"46","author":"Magdaleno-Tapial","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2025.12.036_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bjd\/ljad304","article-title":"Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm","volume":"190","author":"Marin Dit Bertoud","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.036_bib16","first-page":"3442","article-title":"Determination of skin repigmentation progression","volume":"2007","author":"Nugroho","year":"2007","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.jid.2025.12.036_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s41927-018-0031-x","article-title":"In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)","volume":"2","author":"Parmentier","year":"2018","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.jid.2025.12.036_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102655","article-title":"Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study","volume":"73","author":"Passeron","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jid.2025.12.036_bib20","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jdv.18129","article-title":"The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes","volume":"36","author":"Picardo","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.12.036_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790125","article-title":"Janus kinase inhibitors in the treatment of vitiligo: a review","volume":"12","author":"Qi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.12.036_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/pcmr.13056","article-title":"Image analysis systems to calculate the surface area of vitiligo lesions: a systematic review of measurement properties","volume":"35","author":"van Geel","year":"2022","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:24:48Z","timestamp":1786487088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022202X26000370"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.12.036","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}